Conservative strategy in patients with non-ST-segment elevation acute coronary syndromes

Background Clinical outcomes of patients with non ST segment elevation acute coronary syndrome (NSTACS) disqualified from an invasive strategy (InvS) remain incompletely understood Aim To investigate short term results of a conservative strategy (ConS) in a real life population of patients with NSTACS Material and methods 526 patients with NSTACS were retrospectively analysed Of these 335 (63 7%) patients were initially qualified for the ConS In the remaining 191 (36 3%) patients an InvS was applied Results The most frequent reasons for disqualification from an InvS in NSTACS patients were TIMI risk score <= 4 (88 0%) lack of patient consent (3 9%) and pulmonary oedema (3 0%) In the group of InvS cardiogenic shock on admission was found in 11 (5 8%) patients In patients who underwent ConS and InvS 30 day mortality rate was 6 0 and 10 5% (p = 0 061) respectively whereas 30 day mortality in non shock patients assigned to InvS was 79% (p = 040 vs ConS) During primary hospitalization 27 (8 1%) patients with ConS and 7 (3 7%) with InvS developed symptoms of heart failure (Killip 2 4) (p = 0 049) In the group of InvS cardio genic shock on admission (OR 49 5 95% CI 125 234 2 p < 0 0001) and in patients treated conservatively heart failure during hospi talization (OR 274 95% CI48 155 2 p = 0 003) were independent predictors of 30 day mortality (c statistics 0 70) Conclusions In NSTACS patients low risk of complications at baseline was the main reason for disqualification from InvS The mortality rate within 30 days did not differ significantly between the two therapeutic groups Symptoms of heart failure during hos pitalization were an independent predictor of death within 30 days in NSTACS patients disqualified from InvS